A novel disulphide-based PEGylated-nanogels for smart co-delivery of 6-mercaptopurine and methotrexate for effective breast cancer treatment

A novel disulphide-based PEGylated-nanogels for smart co-delivery of 6-mercaptopurine and methotrexate for effective breast cancer treatment


چاپ صفحه
پژوهان
صفحه نخست سامانه
نویسندگان
نویسندگان
اطلاعات تفضیلی
اطلاعات تفضیلی
دانلود مقاله
دانلود مقاله
دانشگاه علوم پزشکی تبریز
دانشگاه علوم پزشکی تبریز

نویسندگان: مرجان قربانی , پریناز نژادمختاری

عنوان کنگره / همایش: 13th International Conference on Emerging And technology , Norway , oslo , 2020

اطلاعات کلی مقاله
hide/show

نویسنده ثبت کننده مقاله مرجان قربانی
مرحله جاری مقاله تایید نهایی
دانشکده/مرکز مربوطه مرکز سلولهای بنیادی
کد مقاله 70872
عنوان فارسی مقاله A novel disulphide-based PEGylated-nanogels for smart co-delivery of 6-mercaptopurine and methotrexate for effective breast cancer treatment
عنوان لاتین مقاله A novel disulphide-based PEGylated-nanogels for smart co-delivery of 6-mercaptopurine and methotrexate for effective breast cancer treatment
نوع ارائه پوستر
عنوان کنگره / همایش 13th International Conference on Emerging And technology
نوع کنگره / همایش بین المللی
کشور محل برگزاری کنگره/ همایش Norway
شهر محل برگزاری کنگره/ همایش oslo
سال انتشار/ ارائه شمسی 1398
سال انتشار/ارائه میلادی 2020
تاریخ شمسی شروع و خاتمه کنگره/همایش 1398/11/27 الی 1398/11/29
آدرس لینک مقاله/ همایش در شبکه اینترنت
آدرس علمی (Affiliation) نویسنده متقاضی Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran,

نویسندگان
hide/show

نویسنده نفر چندم مقاله
مرجان قربانیسوم
پریناز نژادمختاریاول

اطلاعات تفضیلی
hide/show

عنوان متن
خلاصه مقالهNanosized drug delivery approaches have been offered for targeting cancer cells because of their improved permeability and retention effect (EPR), enhanced bioavailability of drugs and the circulation time in the bloodstream. Besides, combination therapy has become an appealing approach for clinical cancer treatment to reach synergistic effects through reducing toxic drugs side effects due to the low drug dose administration. The purpose of this study was to design a biocompatible and novel multi-stimuli responsive polymeric nanogels (PEGIAn-ss-PNIPAAm-ss-PDAEMAQ NGs) for intracellular co-delivery of methotrexate (MTX) and 6-mercaptopurine (MPU) to the MCF7 cell line. The developed NGs revealed many favorable abilities including a narrow size distribution range (60 nm), high drugs loading capacities (26% for MTX and 11% for MPU), and stimuli-responsive drug release. The improved efficiency of the obtained NGs was verified by MTT assay, DAPI staining, and cellular uptake analysis. According to the achieved results, it was concluded that the developed smart NGs have many hopeful abilities for co-delivery of MTX and MPU and can be applied in effective cancer therapy
کلمات کلیدیNanogel; Multi-stimuli responsive; Methotrexate; 6-Mercaptopurine, Cancer

لینک دانلود مقاله
hide/show

نام فایل تاریخ درج فایل اندازه فایل دانلود
Untitled2.jpg1398/11/03153061دانلود
M.pdf1398/11/03788856دانلود